Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Measures the Life Sciences Industry Can Take to Facilitate Diversity in Clinical Trials
-
ナレーター：
-
著者：
このコンテンツについて
Download the White Paper: Diversity in Clinical Trials Participation: A Life Sciences Perspective | https://bit.ly/3LQRFeq
____________________
The importance of ensuring diversity in clinical trials is undisputed, but barriers across the healthcare ecosystem still exist; what can healthcare regulators, policy makers, and manufacturers do to overcome challenges when recruiting clinical trial participants?
Host, Matthew Rube, a Senior Consultant at Trinity Life Sciences, joins two of the subject matter experts that authored Trinity Life Sciences’ cornerstone white paper to discuss why ensuring diversity in clinical trials participation is such a critical issue, the results of the team’s research, and the action-oriented recommendations that they have for the life sciences industry.
Expert Panel:
- Michele Andrews | Principal, Strategic Advisory and Head of the Dynamic Market Intelligence Center of Excellence
- Monique Marsh | Associate Director of Primary Market Research and Head of the Qualitative Research Center of Excellence
____________________
Download the White Paper:
Read Trinity Life Sciences’ white paper ‘Diversity in Clinical Trials Participation: A Life Sciences Perspective’ to understand how you and your organization can help to further diversity in clinical trials.
____________________
Thank you to everyone who contributed towards this important research:
Peter Palumbo, Patrick Hong, Monique Marsh, Shanice O’Brien, Courtney Poopat, Catherine Toal, Michele Andrews, Herman Sanchez, Sumudu Dehipawala, UT Yadav, Alexander Fish, Peter Baek, Alessandra Moscoso, Shruti Nambiar, and Justin Li